-
Something wrong with this record ?
Small phenolic compounds as potential endocrine disruptors interacting with estrogen receptor alpha
R. Alva-Gallegos, E. Jirkovský, P. Mladěnka, A. Carazo
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2010
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
- MeSH
- Estrogen Receptor alpha * metabolism genetics MeSH
- Endocrine Disruptors * pharmacology toxicity MeSH
- Trefoil Factor-1 metabolism genetics MeSH
- Phenols * pharmacology chemistry MeSH
- Humans MeSH
- MCF-7 Cells MeSH
- Breast Neoplasms metabolism MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
The human body is regularly exposed to simple catechols and small phenols originating from our diet or as a consequence of exposure to various industrial products. Several biological properties have been associated with these compounds such as antioxidant, anti-inflammatory, or antiplatelet activity. Less explored is their potential impact on the endocrine system, in particular through interaction with the alpha isoform of the estrogen receptor (ERα). In this study, human breast cancer cell line MCF-7/S0.5 was employed to investigate the effects on ERα of 22 closely chemically related compounds (15 catechols and 7 phenols and their methoxy derivatives), to which humans are widely exposed. ERα targets genes ESR1 (ERα) and TFF1, both on mRNA and protein level, were chosen to study the effect of the tested compounds on the mentioned receptor. A total of 7 compounds seemed to impact mRNA and protein expression similarly to estradiol (E2). The direct interaction of the most active compounds with the ERα ligand binding domain (LBD) was further tested in cell-free experiments using the recombinant form of the LBD, and 4-chloropyrocatechol was shown to behave like E2 with about 1/3 of the potency of E2. Our results provide evidence that some of these compounds can be considered potential endocrine disruptors interacting with ERα.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003802
- 003
- CZ-PrNML
- 005
- 20250206104719.0
- 007
- ta
- 008
- 250121e20241024sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fendo.2024.1440654 $2 doi
- 035 __
- $a (PubMed)39512757
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Alva-Gallegos, Raul $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
- 245 10
- $a Small phenolic compounds as potential endocrine disruptors interacting with estrogen receptor alpha / $c R. Alva-Gallegos, E. Jirkovský, P. Mladěnka, A. Carazo
- 520 9_
- $a The human body is regularly exposed to simple catechols and small phenols originating from our diet or as a consequence of exposure to various industrial products. Several biological properties have been associated with these compounds such as antioxidant, anti-inflammatory, or antiplatelet activity. Less explored is their potential impact on the endocrine system, in particular through interaction with the alpha isoform of the estrogen receptor (ERα). In this study, human breast cancer cell line MCF-7/S0.5 was employed to investigate the effects on ERα of 22 closely chemically related compounds (15 catechols and 7 phenols and their methoxy derivatives), to which humans are widely exposed. ERα targets genes ESR1 (ERα) and TFF1, both on mRNA and protein level, were chosen to study the effect of the tested compounds on the mentioned receptor. A total of 7 compounds seemed to impact mRNA and protein expression similarly to estradiol (E2). The direct interaction of the most active compounds with the ERα ligand binding domain (LBD) was further tested in cell-free experiments using the recombinant form of the LBD, and 4-chloropyrocatechol was shown to behave like E2 with about 1/3 of the potency of E2. Our results provide evidence that some of these compounds can be considered potential endocrine disruptors interacting with ERα.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a alfa receptor estrogenů $x metabolismus $x genetika $7 D047628
- 650 12
- $a endokrinní disruptory $x farmakologie $x toxicita $7 D052244
- 650 12
- $a fenoly $x farmakologie $x chemie $7 D010636
- 650 _2
- $a MFC-7 buňky $7 D061986
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nádory prsu $x metabolismus $7 D001943
- 650 _2
- $a faktor TFF1 $x metabolismus $x genetika $7 D000071163
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jirkovský, Eduard $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
- 700 1_
- $a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
- 700 1_
- $a Carazo, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
- 773 0_
- $w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 15 (20241024), s. 1440654
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39512757 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104714 $b ABA008
- 999 __
- $a ok $b bmc $g 2263526 $s 1239809
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 15 $c - $d 1440654 $e 20241024 $i 1664-2392 $m Frontiers in endocrinology $n Front Endocrinol (Lausanne) $x MED00174543
- LZP __
- $a Pubmed-20250121